Samuel (Chemistry, UAB, 2008) is Group Leader and Deputy Director.at the Institute for Bioengineering of Catalonia. In 2009, he worked at NIMS, Japan, from 2010-2013 he was Group Leader, IFW Dresden, Germany. From 2013-2018 he was Group Leader at the Max Planck Institute for Intelligent Systems, Stuttgart. He was one of the first selected members of the Young Academy of Spain in 2020. He received several awards: Guinness World Record® 2010 and 2017 for smallest jet engine; MIT TR35 “Innovator of the year U35” Spain 2014; Princess of Girona Scientific Award 2015; and National Research Award for Young Talent by FCRi, in 2016, Banco Sabadell Award 2022 and RSEQ Reseach Excellence Award 2022, Constantes y Vitales 2023, and Beca Leonardo in 2024. He obtained the ERC Starting Grant 2012, 4 ERC PoC 2016, 2018, 2021 and 22 and the ERC-Consolidator Grant in 2019. He holds 8 patents, >170 publications, h-index 78 and >20000 cites. He is co-founder, CSO and CEO of Nanobots Therapeutics .S.L.
Research interests
Samuel Sánchez is leader of the “Smart Nano-Bio-Devices” group, working in the multidisciplinary field of Nanosciences with interest in developing hybrid robotics systems across different length-scales, from the nano- to the macroscale. Research interest spans from fundamental science, translational approach of nanodevices to the clinic to the exploitation of the protected intellectual property developed by the group. Currently, the main research lines in the group are: 1. Nanofabrication of nanobots as smart drug delivery systems for biomedical applications.; 2. Study of collective phenomena of active nanosystems; 3. Development of personalized medicine based on multifunctional biocompatible nanobots for patient-derived tumors and other diseases, 4. Use of medical imaging tools to track self-propelled nanobots in vivo and 4. 3D Printing living systems based on skeletal muscle tissues for tissue engineering, drug screening and living soft robotics.
Selected publications
- Ruiz N et al. 2024, 'Swarms of Enzyme-Powered Nanomotors Enhance the Diffusion of Macromolecules in Viscous Media', Small, 20,11.
- Simo, C et al. 2024, 'Urease-powered nanobots for radionuclide bladder cancer therapy', Nat.Nanotech. 19 - 554 - 564.
- Padial TP et al. 2024, 'Synthetic DNA-based Swimmers Driven by Enzyme Catalysis', JACS, 146 - 18.
- Städler B et al. 2024, 'Emerging Life Sciences Series: Q&A with the Editor: Artificial Biology - Assemble, Imitate, Adapt', Adv.Bio. 8 - 9 - 2400256.
- Molina BG et al. 2024, 'Merging BioActuation and BioCapacitive properties: A 3D bioprinted devices to self-stimulate using self-stored energy', Biosens.&Bioelec. 251-116117.
- Serra M et al. 2024, 'Catalase-Powered Nanobots for Overcoming the Mucus Barrier', Acs nano, 18 - 26.
- Fraire JC et al. 2024, 'Swarms of Enzymatic Nanobots for Efficient Gene Delivery', ACS , 16 - 36.
- Lai SFN et al. 2024, 'Real-Time Force Monitoring of Electrically Stimulated 3D-Bioengineered Muscle Bioactuators Using Organic Sensors with Tunable Sensitivity', Adv.Intel.Syst. 2400407.
- Zhang L et al. 2024, 'Introduction to micro- and nano-motors', Nanoscale, 43 - 16.
- Choi H et al. 2024, 'Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy', Nat. Com.15 - 1 - 9934.
- Chen S et al. 2024, 'Collective buoyancy-driven dynamics in swarming enzymatic nanomotors', Nat Com. 15 - 9315.
Selected research activities
-CEO and CSO of Nanobots Therapeutics S.L.
-Chair and Main organizer of the Nanomotors conference 20th Anniversary. Barcelona.
-Editorial Board of Advanced Intelligent Systems
-2 active ERC PoC
-4 covers of journals, including March issue in Nature Nanotechnology
-Article about Nanobots appeared in National Geographic magazine. October 2024
->500 appearances in the media
-Beca Leonardo from BBVA Foundation 2024